Immediate Impact
1 from Science/Nature 63 standout
Citing Papers
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Works of Ken Suzawa being referenced
Acquired MET Exon 14 Alteration Drives Secondary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in EGFR -Mutated Lung Cancer
2019
Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ken Suzawa | 551 | 473 | 490 | 79 | 1.1k | |
| Gonzalo Recondo | 553 | 361 | 616 | 52 | 1.1k | |
| Jia Luo | 443 | 312 | 502 | 63 | 966 | |
| Jing Liu | 427 | 378 | 432 | 71 | 1.1k | |
| Toshio Fujino | 550 | 386 | 407 | 52 | 935 | |
| Jiuda Zhao | 548 | 330 | 722 | 85 | 1.3k | |
| Takuro Kometani | 589 | 551 | 616 | 43 | 1.2k | |
| Chung-Tsen Hsueh | 296 | 406 | 539 | 53 | 1.1k | |
| Ashiq Masood | 355 | 471 | 554 | 51 | 1.2k | |
| Guoshuang Shen | 344 | 292 | 504 | 57 | 945 | |
| Chundong Gu | 353 | 521 | 293 | 47 | 1.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...